AdvisorShares Pure US Cannabis ETF
MSOS

$7.20

2.56%

Market Cap: $894M

0

Funds holding %

of 6,728 funds

–

Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

3% more call options, than puts

Call options by funds: $39.1M | Put options by funds: $37.9M

0% more funds holding

Funds holding: 184 [Q1] → 184 (+0) [Q2]

0% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 33

5.11% less ownership

Funds ownership: 41.26% [Q1] → 36.15% (-5.11%) [Q2]

22% less funds holding in top 10

Funds holding in top 10: 9 [Q1] → 7 (-2) [Q2]

26% less repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 57

29% less capital invested

Capital invested by funds: $448M [Q1] → $319M (-$129M) [Q2]

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for MSOS.

See Analyst Rankings

Financial journalist opinion

Based on 7 articles about MSOS published over the past 30 days

Why Cannabis Is Still An Excellent Long-Term Investment Opportunity

Cannabis investing requires a long-term timeline due to political delays and market volatility; patience is crucial for retail investors. Jesse Redmond highlights why Florida's potential legalization is a massive opportunity, with significant exposure for companies like Trulieve, Ayr, and Cansortium.

Why Cannabis Is Still An Excellent Long-Term Investment Opportunity

Schaeffers Research

Which Sectors Stand to Benefit From Election Outcomes

There will only be two presidential debates this election cycle now that former President Donald Trump declined to debate Vice President and Democratic nominee Kamala Harris a second time. The first debate yielded a clear winner in Trump, while the second one was decidedly positive for Harris, given her surge in the polls in the following days. Because each candidate received a notable bump in the polls after their respective “wins,” investors got a sneak peek into the sectors that stand to benefit most from either administration.

Which Sectors Stand to Benefit From Election Outcomes

Zacks Investment Research

5 ETFs That Led the Rebound on Monday

Wall Street roars back from its biggest weekly losses of the year, driven by bargain hunting and looming Fed rate cuts.

5 ETFs That Led the Rebound on Monday

Proactive Investors

Cannabis stocks rally as Trump backs rescheduling, Florida legalization

Cannabis shares gained traction during Monday's session after Donald Trump endorsed the federal rescheduling of marijuana to allow research into its medical benefits. In a post on his social media platform Truth Social, the Republic presidential candidate said his administration would pass “common sense laws,” specifically the SAFER Banking Act and rescheduling cannabis to the lower-risk Schedule 3 of the Controlled Substances Act.

Cannabis stocks rally as Trump backs rescheduling, Florida legalization

Cannabis stocks rally after Trump supports moving drug to less restrictive category

GOP presidential nominee Donald Trump supports Schedule III classification for cannabis, which has already been proposed by the Biden administration.

Cannabis stocks rally after Trump supports moving drug to less restrictive category

The Motley Fool

Looking for the Next Big Growth Opportunity? It Might Not Be in Artificial Intelligence.

AI stocks have been phenomenal investments in recent years, but investors are paying a high price for them today. Growth investors can generate better returns by targeting undervalued stocks that may have more upside.

Looking for the Next Big Growth Opportunity? It Might Not Be in Artificial Intelligence.

Proactive Investors

Cannabis stocks slide as DEA delays marijuana rescheduling until after the US election

Cannabis stocks moved lower on Tuesday as hopes that marijuana could be rescheduled as a lower-risk drug in the US before the upcoming election in November were dashed. Earlier this year, the Department of Justice (DOJ) in line with a recommendation from the Department of Health and Human Services proposed that because marijuana has accepted medical uses and less abuse potential than other substances in Schedules I and II of the Controlled Substances Act that the drug should be reclassified as Schedule III.

Cannabis stocks slide as DEA delays marijuana rescheduling until after the US election

Cannabis stocks post sharp gains as Trump says he's starting to ‘agree more' about reforms

Cannabis stocks moved sharply higher in late afternoon trading on Thursday after Republican presidential nominee Donald Trump said he's shifting his position in favor of looser cannabis laws.

Cannabis stocks post sharp gains as Trump says he's starting to ‘agree more' about reforms

MSOS: Opportunity And Frustration Ahead

Cannabis demand is high, but investing challenges hinder industry growth due to lack of federal framework. AdvisorShares Pure US Cannabis ETF focuses on US-based cannabis companies, excluding Canadian exposures. MSOS is a basket of top-tier US cannabis companies using swap agreements due to lack of federal legalization, with high concentration and potential volatility.

MSOS: Opportunity And Frustration Ahead

Disruptive Theme of the Week: The Rise of Active Thematic ETFs

This year has been a big year for active ETFs! According to Morningstar, even though actively managed ETFs still only represent 7% of ETF assets, they accounted for 25% of the flows in the first half of this year, growing to a record $889 billion from their start of the year, $714 billion.

Disruptive Theme of the Week: The Rise of Active Thematic ETFs

See News Rankings